Combined Immunotherapy (OK-432, IL-2) With Chemotherapy Decrease the Recurrence Rate in Advanced Ovarian Cancer

Wang Yi-Lun; Peng Hsiu-Huei; Su Sheng-Yuan; Lin Cheng-Tao

首页> 外文期刊>Reproductive sciences >Combined Immunotherapy (OK-432, IL-2) With Chemotherapy Decrease the Recurrence Rate in Advanced Ovarian Cancer

【24h】

Combined Immunotherapy (OK-432, IL-2) With Chemotherapy Decrease the Recurrence Rate in Advanced Ovarian Cancer

机译：联合免疫疗法（OK-432，IL-2）化疗降低晚期卵巢癌中的复发率

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Objective: In advanced ovarian cancer, traditional therapy included debulking surgery and postoperative chemotherapy. We proposed immunochemotherapy (IMCT) combined with picibanil (OK-432), interleukin-2 (IL-2), and traditional platinum- and taxol-based chemotherapy as a better treatment option for advanced ovarian cancer.

机译：目的：在晚期卵巢癌中，传统治疗包括核心手术和术后化疗。我们提出了免疫化学疗法（IMCT）与Picibanil（OK-432），白细胞介素-2（IL-2）和基于传统的铂和紫杉醇的化学疗法相结合，作为晚期卵巢癌的更好的治疗选择。

著录项

来源
《Reproductive sciences》 |2019年第2期|共6页
作者
Wang Yi-Lun; Peng Hsiu-Huei; Su Sheng-Yuan; Lin Cheng-Tao;
展开▼
作者单位

Chang Gung Univ Coll Med Taoyuan Taiwan;

Chang Gung Mem Hosp Dept Obstet &

Gynecol Taoyuan Taiwan;

Chang Gung Mem Hosp Dept Obstet &

Gynecol Taoyuan Taiwan;

Chang Gung Mem Hosp Dept Obstet &

Gynecol Taoyuan Taiwan;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类产科学;
关键词
advanced ovarian cancer; chemotherapy; immunotherapy; picibanil (OK-432); interleukin-2 (IL-2);

机译：晚期卵巢癌;化疗;免疫疗法;皮比尔（OK-432）;白细胞介素-2（IL-2）;

相似文献

外文文献
中文文献
专利

1. Combined Immunotherapy (OK-432, IL-2) With Chemotherapy Decrease the Recurrence Rate in Advanced Ovarian Cancer [J] . Wang Yi-Lun, Peng Hsiu-Huei, Su Sheng-Yuan, Reproductive sciences . 2019,第2期

机译：联合免疫疗法（OK-432，IL-2）化疗降低晚期卵巢癌中的复发率
2. Effect of immunotherapy combined with intravenous chemotherapy on the tumor load, immune function and cancer cell proliferation activity in patients with advanced colon cancer [J] . En-Lin Zhang Journal of Hainan Medical University . 2017,第18期

机译：免疫疗法联合静脉化疗对晚期结肠癌患者肿瘤负荷，免疫功能和癌细胞增殖活性的影响
3. Effect of immunotherapy combined with intravenous chemotherapy on the tumor load,immune function and cancer cell proliferation activity in patients with advanced colon cancer [J] . En-Lin Zhang 海南医科大学学报（英文版） . 2017,第018期

机译：免疫疗法联合静脉化疗对晚期结肠癌患者肿瘤负荷，免疫功能和癌细胞增殖活性的影响
4. Clinical Outcome of Breast and Ovarian Cancer Patients Treated after High-Dose Chemotherapy and Autologous Stem Cell Rescue with Theratope (STn-KLH) Cancer Vaccine: Theratope (STn-KLH) Cancer Vaccine following Autologous Transplant [C] . Leona A. Holmberg, Katherine A. Guthrie, Brenda M. Sandmaier Chemical glycobiology . -1

机译：大剂量化学疗法和自体干细胞拯救治疗的Theratope（STn-KLH）癌症疫苗治疗的乳腺癌和卵巢癌患者的临床结果：自体移植后的Theratope（STn-KLH）癌症疫苗
5. The Evolution of Hyperthermic Intraperitoneal Chemotherapy in The Setting of Advanced Ovarian Cancer [D] . Quindlen, Kevin J. 2019

机译：高温腹膜内化疗的演变在晚期卵巢癌的环境中
6. Combined chemotherapy and allogeneic human Vγ9Vδ2 T lymphocyte-immunotherapies efficiently control the development of human epithelial ovarian cancer cells in vivo [O] . Noémie Joalland, Laura Lafrance, Thibauld Oullier, 2019

机译：联合化疗和同种异体人Vγ9Vδ2T淋巴细胞免疫疗法可有效控制体内人上皮性卵巢癌细胞的发展
7. 237O Effects of neoadjuvant hyperthermic intraperitoneal chemotherapy on chemotherapy response score and recurrence for high-grade serous ovarian cancer patients with advanced disease [O] . J. Li, M-F. Wu, H. Li, 2020

机译：237O对高级浆膜卵巢癌患者的高级浆膜癌患者进行新辅助热热腹膜内化疗对高级血液癌症患者的影响

Combined Immunotherapy (OK-432, IL-2) With Chemotherapy Decrease the Recurrence Rate in Advanced Ovarian Cancer

摘要

著录项

相似文献

相关主题

期刊订阅